Free Trial

ATI Physical Therapy (ATIP) Competitors

ATI Physical Therapy logo
$5.50
+0.12 (+2.23%)
(As of 11/1/2024 ET)

ATIP vs. ENZ, XGN, CCM, BNR, TOI, RNLX, OPGN, PMD, BRTX, and MRAI

Should you be buying ATI Physical Therapy stock or one of its competitors? The main competitors of ATI Physical Therapy include Enzo Biochem (ENZ), Exagen (XGN), Concord Medical Services (CCM), Burning Rock Biotech (BNR), Oncology Institute (TOI), Renalytix (RNLX), OpGen (OPGN), Psychemedics (PMD), BioRestorative Therapies (BRTX), and Marpai (MRAI). These companies are all part of the "healthcare" industry.

ATI Physical Therapy vs.

ATI Physical Therapy (NYSE:ATIP) and Enzo Biochem (NYSE:ENZ) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, community ranking, media sentiment, dividends, risk, profitability and institutional ownership.

In the previous week, Enzo Biochem had 7 more articles in the media than ATI Physical Therapy. MarketBeat recorded 8 mentions for Enzo Biochem and 1 mentions for ATI Physical Therapy. ATI Physical Therapy's average media sentiment score of 0.50 beat Enzo Biochem's score of 0.28 indicating that ATI Physical Therapy is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ATI Physical Therapy
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Enzo Biochem
0 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

ATI Physical Therapy has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500. Comparatively, Enzo Biochem has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ATI Physical Therapy
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Enzo Biochem
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Enzo Biochem received 197 more outperform votes than ATI Physical Therapy when rated by MarketBeat users. Likewise, 55.64% of users gave Enzo Biochem an outperform vote while only 36.59% of users gave ATI Physical Therapy an outperform vote.

CompanyUnderperformOutperform
ATI Physical TherapyOutperform Votes
15
36.59%
Underperform Votes
26
63.41%
Enzo BiochemOutperform Votes
212
55.64%
Underperform Votes
169
44.36%

Enzo Biochem has lower revenue, but higher earnings than ATI Physical Therapy.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ATI Physical Therapy$699.02M0.04-$69.79M-$13.61-0.41
Enzo Biochem$31.91M1.85$20.29MN/AN/A

ATI Physical Therapy has a net margin of -5.38% compared to Enzo Biochem's net margin of -81.73%. ATI Physical Therapy's return on equity of 0.00% beat Enzo Biochem's return on equity.

Company Net Margins Return on Equity Return on Assets
ATI Physical Therapy-5.38% N/A -3.96%
Enzo Biochem -81.73%-11.84%-8.31%

72.6% of ATI Physical Therapy shares are held by institutional investors. Comparatively, 36.9% of Enzo Biochem shares are held by institutional investors. 3.3% of ATI Physical Therapy shares are held by insiders. Comparatively, 15.5% of Enzo Biochem shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Enzo Biochem beats ATI Physical Therapy on 7 of the 13 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATIP vs. The Competition

MetricATI Physical TherapyNursing & personal care facilities IndustryMedical SectorNYSE Exchange
Market Cap$24.77M$523.72M$5.33B$19.27B
Dividend YieldN/AN/A5.07%3.53%
P/E Ratio-0.4116.09128.5843.29
Price / Sales0.040.241,490.3714.55
Price / Cash0.954.8839.6220.89
Price / Book-0.231.574.765.40
Net Income-$69.79M-$225.94M$118.92M$985.39M
7 Day Performance-4.41%7.17%0.78%-0.71%
1 Month Performance-7.86%5.32%5.62%-0.98%
1 Year Performance-23.51%-13.94%36.67%25.02%

ATI Physical Therapy Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATIP
ATI Physical Therapy
1.6517 of 5 stars
$5.50
+2.2%
N/A-19.3%$24.20M$699.02M-0.405,600Upcoming Earnings
Short Interest ↓
News Coverage
ENZ
Enzo Biochem
0.5822 of 5 stars
$1.13
-1.7%
N/A-15.7%$59.03M$31.91M0.00520Dividend Announcement
Analyst Forecast
News Coverage
XGN
Exagen
4.1971 of 5 stars
$2.57
+5.8%
$7.00
+172.4%
+48.6%$44.69M$52.55M-2.65220Negative News
CCM
Concord Medical Services
1.6687 of 5 stars
$7.89
+2.2%
N/AN/A$34.26M$75.69M0.00970Analyst Forecast
Short Interest ↓
News Coverage
Gap Down
BNR
Burning Rock Biotech
0.7289 of 5 stars
$2.71
-3.6%
N/A-70.3%$27.75M$75.70M-0.561,390Gap Down
TOI
Oncology Institute
2.3103 of 5 stars
$0.30
-3.2%
$2.50
+733.6%
-85.7%$22.64M$324.24M-0.38660Gap Down
RNLX
Renalytix
1.2397 of 5 stars
$0.21
+5.7%
$3.00
+1,348.6%
-79.7%$17.18M$2.29M-0.53100Gap Up
OPGN
OpGen
N/A$1.81
+8.4%
N/A-72.0%$15.10M$2.67M0.00100Analyst Forecast
News Coverage
Gap Up
PMD
Psychemedics
N/A$2.32
-0.4%
N/A-6.5%$13.67M$20.79M-2.97140Positive News
High Trading Volume
BRTX
BioRestorative Therapies
4.0457 of 5 stars
$1.58
+1.3%
$18.00
+1,039.2%
-12.2%$10.93M$150,000.00-0.777Short Interest ↓
Positive News
MRAI
Marpai
N/A$0.72
-23.4%
$6.00
+733.3%
+76.9%$9.89M$37.15M-0.22150

Related Companies and Tools


This page (NYSE:ATIP) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners